Abstract -Influenza viruses bind to host cells by attachment to sialic acid containing oligosaccharides on cell surface glycoproteins and glycolipids. We have examined the receptor specificity of influenza viruses using an approach employing highly purified mammalian sialyltransferases.
INTRODUCTION
Influenza viruses infect a variety ofspecies including man, pigs, horses, seals and birds (Ref. 1) . The virus has a membrane envelope with two types of surface glycoproteins, the hemagglutinin and the neuraminidase, both of which interact with sialyloligosaccharides on host cells. Over thirty years ago it was found that pretreatment of erythrocytes or host cells with bacterial sialidase abolished viral adsorption and/or infection, demonstrating that sialic acid is an essential feature of the receptor determinant (Ref. 2, 3) . It is the hemagglutinin which mediates attachment to the cell, named for its activity in causing viral agglutination of erythrocytes. The neuraminidase is capable of hydrolyzing sialic acid from receptors, and at high levels in an infected cell aids in elution of the budding virus from the host membrane. Early observations suggested that influenza virus hemagglutinins could differ in their binding properties. Notably, graded sialidase treatment of erythrocytes abolished agglutination of certain viruses before that of others (Ref. 4 ) and soluble sialoglycoproteins acting as receptor analogs caused inhibition of hemagglutination only for some viruses (Ref. 5, 6 ).
In recent years we have sought to examine the detailed binding specificity of influenza virus hemagglutinins to understand the basis of differential receptor binding properties observed previously, and to determine how such specificity may influence the biology of the virus. Because sialyloligosaccharides of cell surface glycoproteins and glycolipids exhibit considerable diversity, the interaction of the virus with cell surface molecules may be very complex. To reduce this complexity, enzymatic modification of cell surface oligosaccharides is used to prepare cells with a single sialyloligosaccharide receptor determinant. Analysis of the ability of influenza viruses to bind to these cells has revealed that influenza virus hemagglutinins recognize aspects of oligosaccharide structure beyond the terminal sialic acid. Indeed, two influenza isolates may exhibit very different receptor specificities. As discussed below, receptor specific viruses may be differentially subject to selective pressures at the level of virus adsorption to the host cell surface.
ENZYMATIC MODIFICATION OF CELL SURFACE SIALYLOLIGOSACCHARIDES
As depicted in Fig. 1 , cells may in principle be modified to carry sialic acid in a single sequence by a two-step enzymatic procedure. This has been successfully applied to analysis of animal virus receptors on erythrocytes and tissue culture cells (Ref. Note a. Sialic acid is abbreviated SA. Unless otherwise indicated sialic acid refers to N-acetylneuraminic acid.
As many as twelve sialyltransferases may be required to elaborate all the oligosaccharide structures reported on glycoproteins and glycolipids to date. Of these, four sialyltransferases have been purified to homogeneity and their use as enzymatic tools in analysis of oligosaccharide structure and function has been described (Ref. 9, 10) . These four enzymes together elaborate the most common sialylated sequences found on glycoprotein oligosaccharides N-linked to asparagine and 0-linked to threonine or serine as shown in Fig. 2 . All four enzymes have been used in analysis of influenza virus receptor specificity.
VARIATION IN RECEPTOR SPECIFICITY OF INFLUENZA VIRUS HEMAGGLUTININS
Binding to resialylated erythrocytes. To date nearly thirty influenza virus isolates have been examined for their agglutination of human erythrocyte preparations derivatized to carry the four sialyloligosaccharide sequences shown in Fig. 2 (Ref. 7, 11, 12) . Over 90% of the sialic acid incorporated by the sialyltransferases is attached to glycoprotein ohgosaccharides, most being transferred to glycophorin which contains one N-linked oligosaccharide and 15 0-linked oligosaccharides similar to those shown in Fig. 2 (Ref. 7) . In the following discussion the sialyloligosaccharide sequences will be abbreviated by a disaccharide sequence and a Roman numeral which refers to the complete structure in Two types of assays are shown, direct adsorption (panel A) in which virus is bound to erythrocytes and the washed cells assessed for associated viral neuraminidase, and hanagglutination, in which the ability of the virus to cause agglutination of the cells is examined. Good correspondence between the two binding assays is observed. In general, three main binding types are found. Some viruses preferentially bind cells containing the SAa2,6Gal(I) sequence, some preferentially bind cells containing the SAz2,3Gal(III) sequence, and some bind cells containing either sequence. Viruses that bind to cells containing the SAa2,3Gal(III) sequence also bind the SAa2,3Gal(II) sequence. However, the converse is not true. As shown by the work of Schauer and colleagues, the sialic acids are a family of at least 23 natural compounds which can differ by their N-and 0-acyl substituents (Ref. 13 ). The type of sialic acids found in glycoconjugates varies greatly from species to species. In most of the experiments described here, the sialic acid used is N-acetylneuraminic acid (Neu5Ac), the predominant sialic acid in humans. Recently we have prepared the sialyltransferase donor substrates CMP-11-glycollylneuraminic acid (CMP-Neu5Gc) and CMP-9-Oacetyl-N-acetylneuraminic acid (CMP-9-O-Ac-Neu5Ac) in addition to CMP-N-acetylneuraminic acid (CMP-1'ieu5Ac). With these analogs it has been possible to prepare erythrocytes contaming the SA2,6Ga1(I) and SAz2,3Gal(III) linkages with each of the corresponding sialic acids. From initial experiments examining the adsorption of influenza viruses to these cells, several conclusions can be drawn. Some viruses bind equally well to cells containing Neu5Ac or Neu5Gc while others bind only the former. None of the viruses which bind the SAcz2,6Gal(I) sequence with Neu5Ac will bind the same sequence with 9-OAc-Neu5Ac. Thus, the 9-0-acetyl substitution appears to interfere with binding. These results mdicate that influenza virus hemagglutinins can distinguish between naturally occurring sialic acid analogs in addition to the sequence to which the sialic acid is attached.
Interaction of influenza viruses with neoglycoproteins. Analysis of the binding of influenza viruses to receptor modified erythrocytes has proven a sensitive and reliable method of distinguishing differences in receptor binding properties. A virus (M1/5) exhibiting specificity for binding the SAa2,6Gal linkage was tested for inhibition of hemagglutination by sialylated neoglycoproteins and free sialyloligosaccharides. A fixed amount of virus was mixed with serial dilutions of each derivative in a microtiter plate, and then challenged with a suspension of native erythrocytes. Results are expressed as the minimum concentration (based on sialic acid content) required to inhibit hernagglutination. Sialylated neoglycoproteins were prepared by coupling to bovine serum albumin (BSA) by the method of Leeet al. (14) followed by enzymatic addition of galactose with the N-acetylglucosaminide f31,4 galactosyltransferase and N-acetylneuraminic acid with the Ga1B1,4G1cNAc a2,6 sialyltransferase or the Ga1B1,3(4)G1cNAc ci2,3 sialyltransferase. In this way derivatives containing the SAcx2,6GalBl,4 G1cNAc and SAa2,3Ga1B1,4GlcMAc sequences were obtained with 33 mol and 22 mol oligosaccharide per mol bovine serum albumin, respectively. The corresponding free trisaccharides were similarly prepared by sialylation of * No inhibition at highest concentration tested.
were tested for their ability to inhibit hemagglutination by a laboratory strain of influenza virus, M1/5, which exhibits a receptor specificity with preferential binding of the SAa2,6Gal(I) sequence. Of the two neoglycoproteins tested only the one containing the SAci2,6Gal linkage inhibited hemagglutination, in keeping with the known specificity of the M1/5 virus hemagglutinin. Also tested as inhibitors of heniagglutination were two trisaccharides identical in sequence to those attached to the multivalent neoglycoproteins ( Glycoprotein inhibitors of infection. The extreme sensitivity of human H3 isolates to inhibition of hemagglutination by horse serum or equine a2 macroglobulin (Table II) In the absence of inhibitor the progeny virus exhibits the receptor specificity of the parent virus, binding with strict specificity to cells containing the SAa2,6Gal(I) sequence. In contrast, when grown in the presence of horse serum or equine a macroglobulin, the progeny virus exhibits a specificity characteristic of the avian and equine isolates, binding preferentially to cells containing the SAcz2,3Gal(III) sequence. In each case, the SAa2,3Gal(III) specific variants are, as expected, insensitive to inhibition of hemagglutination or infection by horse serum (see also Ref. 20, 27) . These results provide a rationale for selection and maintenance of a SAa2,3Gal ( It is also of interest to understand the molecular features of a glycoprotein inhibitor that enables it to combine with the hemaggutinin with sufficient avidity to inhibit infection. Molecular weight, high valency, and the spatial arrangement of the sialyloligosaccharides have been proposed to be important in the interaction of glycoprotein inhibitors with influenza viruses (Ref. 29, 30) . In view of the forgoing discussion, oligosaccharide structure must also be important. While equine a macroglobulin is a potent inhibitor of infection of human H3 isolates, human a niacroglobulin is a poor inhibitor. Yet both glycoproteins have similar molecular weight and sial ic acid content. Differential adsorption to cell surface receptors. Selection of the SAa2,6Gal(I) specific inhibitor sensitive properties observed for human H3 isolates cannot be readily explained by selective suppression of the contrasting SAa2,3Gal(III) specific phenotype with glycoprotein inhibitors of infection. Indeed, no glycoprotein yet tested is an effective inhibitor of hemagglutination of viruses with the inhibitor insensitive H3 hemagglutinin, including glycophorin which presumably is the predominant receptor on erythrocytes. An alternate means of selection for the SAa2,6Gal(I) specific inhibitor sensitive phenotype could be differential adsorption to cell surface receptors.
To test the potential for sialyloligosaccharides on host cells to select receptor specific variants of influenza virus, we have examined influenza virus infections of tissue culture cells enzyinatically modified as outlined in Fig. 1 
CONCLUDING REMARKS
It is evident that influenza viruses exhibit considerable diversity in recognition of specific sialyloligosaccharide structures as cell surface receptor determinants. It is also apparent from laboratory models that such specificity can provide the basis for selection of receptor specific variants. Does such selection occur naturally? Indirect evidence comes from the correlation of receptor specificity and species of origin observed for influenza isolates bearing the H3 hemagglutinin (Ref. 12,20; Table II ). There are also several instances in which changes in receptor binding properties have been documented to occur upon adaptation of human influenza viruses to growth invivo (chicken embryos). Burnet and Bull (Ref. 35) and Stone (Ref. 36) found that human Hi viruses as isolated preferentially agglutinated human erythrocytes to a higher titer than chicken erythrocytes, but after growth inovo agglutinated erythrocytes of both species equally well. More recently, growth of human influenza B viruses inovo has been found to select for an antigenic variant different from that which predominates in the human host (Ref. 37 ). The original virus and egg adapted variant was also found to differ in their agglutination of erythrocytes of different species. In each of these cases the cause of selection or maintenance of variants with different receptor binding properties has not been identified. It will be of interest to identify the factors responsible for selection of receptor variants in natural hosts of influenza in order to better understand the role of receptor specificity in the biology of the virus. 
